BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 8374521)

  • 1. Induction of differentiation of B-cell leukemia cell lines JVM-2 and EHEB by bryostatin 1.
    Hu ZB; Gignac SM; Uphoff CC; Quentmeier H; Steube KG; Drexler HG
    Leuk Lymphoma; 1993 May; 10(1-2):135-42. PubMed ID: 8374521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bryostatin 1 induces differentiation of B-chronic lymphocytic leukemia cells.
    Drexler HG; Gignac SM; Jones RA; Scott CS; Pettit GR; Hoffbrand AV
    Blood; 1989 Oct; 74(5):1747-57. PubMed ID: 2506950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Down-regulation of CD5 mRNA in B-chronic lymphocytic leukemia cells by differentiation-inducing agents.
    Gignac SM; Buschle M; Hoffbrand AV; Drexler HG
    Eur J Immunol; 1990 May; 20(5):1119-23. PubMed ID: 1694132
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of proto-oncogene c-jun during differentiation of B-chronic lymphocytic leukemia.
    Gignac SM; Buschie M; Pettit GR; Hoffbrand AV; Drexler HG
    Leukemia; 1990 Jun; 4(6):441-4. PubMed ID: 2113601
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bryostatin 1-induced modulation of the acute lymphoblastic leukemia cell line Reh.
    al-Katib A; Mohammad RM; Khan K; Dan ME; Pettit GR; Sensenbrenner LL
    J Immunother Emphasis Tumor Immunol; 1993 Jul; 14(1):33-42. PubMed ID: 8399068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation and growth modulation of myeloid leukemia cells by the protein kinase C activating agent bryostatin-1.
    Steube KG; Drexler HG
    Leuk Lymphoma; 1993 Jan; 9(1-2):141-8. PubMed ID: 8477194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of dolastatins on human B-lymphocytic leukemia cell lines.
    Hu ZB; Gignac SM; Quentmeier H; Pettit GR; Drexler HG
    Leuk Res; 1993 Apr; 17(4):333-9. PubMed ID: 8487581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Different biological effects of the two protein kinase C activators bryostatin-1 and TPA on human carcinoma cell lines.
    Steube KG; Grunicke D; Drexler HG
    Invest New Drugs; 1994; 12(1):15-23. PubMed ID: 7960600
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different effects of the two protein kinase C activators bryostatin-1 and TPA on growth and differentiation of human monocytic leukemia cell lines.
    Steube KG; Grunicke D; Quentmeier H; Drexler HG
    Leuk Res; 1993 Oct; 17(10):897-901. PubMed ID: 8412301
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bryostatin induces protein kinase C modulation, Mcl-1 up-regulation and phosphorylation of Bcl-2 resulting in cellular differentiation and resistance to drug-induced apoptosis in B-cell chronic lymphocytic leukemia cells.
    Thomas A; Pepper C; Hoy T; Bentley P
    Leuk Lymphoma; 2004 May; 45(5):997-1008. PubMed ID: 15291360
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bryostatin 1-induced hairy cell features on chronic lymphocytic leukemia cells in vitro.
    al-Katib A; Mohammad RM; Dan M; Hussein ME; Akhtar A; Pettit GR; Sensenbrenner LL
    Exp Hematol; 1993 Jan; 21(1):61-5. PubMed ID: 8093352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Differentiation and growth modulation of chronic myelogenous leukemia cells by bryostatin.
    Lilly M; Tompkins C; Brown C; Pettit G; Kraft A
    Cancer Res; 1990 Sep; 50(17):5520-5. PubMed ID: 2386956
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of bryostatins 1 and 2 on morphological and functional differentiation of SH-SY5Y human neuroblastoma cells.
    Jalava AM; Heikkilä J; Akerlind G; Pettit GR; Akerman KE
    Cancer Res; 1990 Jun; 50(11):3422-8. PubMed ID: 2334938
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infrared spectroscopic study of bryostatin 1-induced membrane alterations in a B-CLL cell line.
    Liu KZ; Schultz CP; Johnston JB; Beck FW; Al-Katib AM; Mohammad RM; Mantsch HH
    Leukemia; 1999 Aug; 13(8):1273-80. PubMed ID: 10450757
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sequential treatment of human chronic lymphocytic leukemia with bryostatin 1 followed by 2-chlorodeoxyadenosine: preclinical studies.
    Mohammad RM; Katato K; Almatchy VP; Wall N; Liu KZ; Schultz CP; Mantsch HH; Varterasian M; al-Katib AM
    Clin Cancer Res; 1998 Feb; 4(2):445-53. PubMed ID: 9516935
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Divergent effects of bryostatin 1 and phorbol myristate acetate on cell cycle arrest and maturation in human myelomonocytic leukemia cells (U937).
    Vrana JA; Saunders AM; Chellappan SP; Grant S
    Differentiation; 1998 May; 63(1):33-42. PubMed ID: 9615391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5'-NT and Bax/Bcl-2.
    Mohammad RM; Beck FW; Katato K; Hamdy N; Wall N; Al-Katib A
    Biol Chem; 1998 Oct; 379(10):1253-61. PubMed ID: 9820586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT1 mediates differentiation of chronic lymphocytic leukemia cells in response to Bryostatin 1.
    Battle TE; Frank DA
    Blood; 2003 Oct; 102(8):3016-24. PubMed ID: 12855573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differentiating agents do not induce a true hairy cell phenotype in B-CLL cells in vitro.
    Gartenhaus R; Hoffman M; Fuchs A; Billet H; Wang P; Gentile P; Rai K
    Leuk Lymphoma; 1996 Jun; 22(1-2):97-101, follow.186, color plate IX. PubMed ID: 8724534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 1alpha,25-dihydroxyvitamin D3 and bryostatin-1 synergize to induce monocytic differentiation of NB4 acute promyelocytic leukemia cells by modulating cell cycle progression.
    Clark CS; Konyer JE; Meckling KA
    Exp Cell Res; 2004 Mar; 294(1):301-11. PubMed ID: 14980523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.